case_images: PMC11043615_01
case_images: Chest computed tomography image (A) and chest X-rays (B) before the introduction of extracorporeal membrane oxygenation. (A) Bilateral ground-glass opacities (arrow) are shown, indicating pulmonary edema. (B) The diffuse infiltration throughout all lung fields is shown.
case_images: AMS2-11-e957-g002.jpg
case_images: PMC11043615_01_AMS2-11-e957-g002.jpg
case_images: ams2957-fig-0001
case_images: Chest computed tomography (CT) was performed immediately thereafter, and the CT image showed bilateral ground-glass opacities (Figure 1A). The post-intubation chest X-ray showed diffuse infiltration throughout all lung fields (Figure 1B). The course of treatment and the laboratory results of the patient at each time point were shown in Figure 2 and Table S1.
case_images: Clinical course and treatment process. Extracorporeal membrane oxygenation (ECMO) was introduced and a neuromuscular blocking agent (NMBA) and methylprednisolone (mPSL) were administered on day 1. With improvement in dynamic lung compliance and the chest X-ray, NMBA was finally discontinued on day 6. The dose of mPSL was gradually reduced. However, the patient developed ventilator-associated pneumonia (VAP) and antibiotics were started on day 8. After improvement in VAP, the ECMO was weaned off on day 11. ECMO, extracorporeal membrane oxygenation; ICU, intensive care unit; mPSL, methylprednisolone; NMBA, neuromuscular blocking agent.
case_images: AMS2-11-e957-g003.jpg
case_images: PMC11043615_01_AMS2-11-e957-g003.jpg
case_images: ams2957-fig-0002
case_images: The course of treatment and the laboratory results of the patient at each time point were shown in Figure 2 and Table S1.